BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33292120)

  • 1. Evolutionary Timeline of Genetic Delivery and Gene Therapy.
    Holl NJ; Lee HJ; Huang YW
    Curr Gene Ther; 2021; 21(2):89-111. PubMed ID: 33292120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy: Comprehensive overview and therapeutic applications.
    Sayed N; Allawadhi P; Khurana A; Singh V; Navik U; Pasumarthi SK; Khurana I; Banothu AK; Weiskirchen R; Bharani KK
    Life Sci; 2022 Apr; 294():120375. PubMed ID: 35123997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Therapeutic Genome Editing in China.
    Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
    Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene editing technology for improving life quality: A dream coming true?
    Ramezankhani R; Minaei N; Haddadi M; Torabi S; Hesaraki M; Mirzaei H; Vosough M; Verfaillie CM
    Clin Genet; 2021 Jan; 99(1):67-83. PubMed ID: 32506418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss.
    Farooq R; Hussain K; Tariq M; Farooq A; Mustafa M
    J Appl Genet; 2020 Feb; 61(1):51-65. PubMed ID: 31912450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in genome editing of stem cells for drug discovery and therapeutic application.
    Lee J; Bayarsaikhan D; Bayarsaikhan G; Kim JS; Schwarzbach E; Lee B
    Pharmacol Ther; 2020 May; 209():107501. PubMed ID: 32061705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas gene therapy.
    Zhang B
    J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The delivery challenge: fulfilling the promise of therapeutic genome editing.
    van Haasteren J; Li J; Scheideler OJ; Murthy N; Schaffer DV
    Nat Biotechnol; 2020 Jul; 38(7):845-855. PubMed ID: 32601435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonviral Nanoparticles for CRISPR-Based Genome Editing: Is It Just a Simple Adaption of What Have Been Developed for Nucleic Acid Delivery?
    Qiu M; Glass Z; Xu Q
    Biomacromolecules; 2019 Sep; 20(9):3333-3339. PubMed ID: 31342740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for inborn errors of immunity: Base editing comes into play.
    Malech HL; Notarangelo LD
    Cell; 2023 Mar; 186(7):1302-1304. PubMed ID: 37001495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases.
    Wu SS; Li QC; Yin CQ; Xue W; Song CQ
    Theranostics; 2020; 10(10):4374-4382. PubMed ID: 32292501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases.
    Kolli N; Lu M; Maiti P; Rossignol J; Dunbar GL
    Neurochem Int; 2018 Jan; 112():187-196. PubMed ID: 28732771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome editing in large animal models.
    Maynard LH; Humbert O; Peterson CW; Kiem HP
    Mol Ther; 2021 Nov; 29(11):3140-3152. PubMed ID: 34601132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic editing of hepatocyte genome in vivo.
    Ruiz de Galarreta M; Lujambio A
    J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR gene editing in human embryos wreaks chromosomal mayhem.
    Ledford H
    Nature; 2020 Jul; 583(7814):17-18. PubMed ID: 32606465
    [No Abstract]   [Full Text] [Related]  

  • 20. CRISPR Genome Editing Technology and its Application in Genetic Diseases: A Review.
    Khatibi S; Sahebkar A; Aghaee-Bakhtiari SH
    Curr Pharm Biotechnol; 2021; 22(4):468-479. PubMed ID: 32564746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.